Connecticut joined 35 states and D.C. in a $36.5 million settlement after CVS overbilled Medicaid for insulin pen claims.

Insulin and equipment shortages in Gaza pose fatal risks, leading to critical health complications.

CHARLOTTE, N.C. (QUEEN CITY NEWS) — As the popularity of GLP-1 medications for weight loss continues to soar, experts in ...

We can freeze your eggs, but why now? You’re still young. Find a guy!” He did not supplement his moral prescription with clinical investigation. Rubab’s foray into reproductive autonomy explains one ...

Hawaiʻi will receive $617,160 from a national CVS Pharmacy settlement resolving civil allegations that the company submitted ...

Life-saving medicines used by millions of people in Britain, including insulin, asthma inhalers and weight-loss drugs, can ...

A rare red warning for extreme heat has been issued by the Met Office as the UK has sweltered in exceptionally hot and humid ...

Duopharma Biotech Bhd said its subsidiary hoped to improve diabetes management in the country by providing high-quality and cost-effective biosimilar insulin. (Bernama pic) Duopharma Biotech Bhd’s ...

A rebound for AI stocks lifted the U.S. market. The S&P 500 rose 0.7% Monday and pulled within 1% of its record, even though the majority of stocks within the index fell. The strength for AI sent ...

Adolescents can sometimes miss mealtime insulin because it’s hard to take a shot in front of other people,” Dr. Risa Wolf ...

The U.S. Supreme Court has declined to block Texas from enforcing a state law that requires age verification and parental ...

Ozempic is a brand-name glucagon-like peptide-1 (GLP-1) medication approved by the U.S. Food and Drug Administration (FDA) to manage blood sugar in individuals with type 2 diabetes. In May 2026, ...